| Funding Opportunity ID: | 333436 | | Opportunity Number: | W81XWH-21-MSRP-CTA | | Opportunity Title: | DOD Multiple Sclerosis Clinical Trial Award | | Opportunity Category: | Discretionary | | Opportunity Category Explanation: | | | Funding Instrument Type: | Cooperative Agreement
Grant | | Category of Funding Activity: | Science and Technology and other Research and Development | | Category Explanation: | | | CFDA Number(s): | 12.420 | | Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” | | Additional Information on Eligibility: | | | Agency Code: | DOD-AMRAA | | Agency Name: | Department of Defense
Dept. of the Army — USAMRAA | | Posted Date: | May 10, 2021 | | Close Date: | Oct 01, 2021 | | Last Updated Date: | May 10, 2021 | | Award Ceiling: | $0 | | Award Floor: | $0 | | Estimated Total Program Funding: | $8,000,000 | | Expected Number of Awards: | 3 | | Description: | The MSRP Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of multiple sclerosis. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first in human, phase 0), to demonstrate feasibility or inform the design of more advanced trials, through larger-scale phase 1 or phase 2 trials to determine safety or efficacy in relevant patient populations. | | Version: | 1 |
|
